Discovery and SAR of 4-amino-2-biarylbutylurea MCH 1 receptor antagonists through solid-phase parallel synthesis.

Bioorg Med Chem Lett

Pharmacopeia Drug Discovery, Inc., P.O. Box 5350, Princeton, NJ 08543-5350, USA.

Published: August 2005

-4-Amino-2-arylbutylbenzamides such as 1 were identified as micromolar MCH 1 receptor (MCH1R) antagonists via screening using a scintillation proximity assay based on [125I]-MCH binding to recombinant, human MCH1R. Subsequent lead optimization efforts using solid-phase parallel synthesis resulted in the defined structure-activity relationships and the identification of 4-amino-2-biarylbutylureas, such as 11g, as potent single digit nanomolar MCH1R antagonists.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2005.05.039DOI Listing

Publication Analysis

Top Keywords

mch receptor
8
solid-phase parallel
8
parallel synthesis
8
mch1r antagonists
8
discovery sar
4
sar 4-amino-2-biarylbutylurea
4
4-amino-2-biarylbutylurea mch
4
receptor antagonists
4
antagonists solid-phase
4
synthesis -4-amino-2-arylbutylbenzamides
4

Similar Publications

Article Synopsis
  • - Atypical depression (AD) is a subtype of depression characterized by mood reactivity and features like increased appetite, hypersomnia, and sensitivity to interpersonal rejection, with a focus on the genetic factors influencing its development.
  • - Recent research found nine studies linking specific genetic markers, including those related to the serotonin transporter gene and other regulatory genes, to atypical depression, although no comprehensive reviews on this topic exist yet.
  • - The findings suggest that atypical depression has a hereditary component, indicating that identifying individual genetic risk markers for AD could be a significant area for future research.
View Article and Find Full Text PDF

Melanin-concentrating hormone promotes feeding through the lateral septum.

Prog Neuropsychopharmacol Biol Psychiatry

October 2024

Department of Neuroscience, Carleton University, Ottawa, ON K1S 5B6, Canada. Electronic address:

Feeding is necessary for survival but can be hindered by anxiety or fear, thus neural systems that can regulate anxiety states are key to elucidating the expression of food-related behaviors. Melanin-concentrating hormone (MCH) is a neuropeptide produced in the lateral hypothalamus and zona incerta that promotes feeding and anxiogenesis. The orexigenic actions of MCH that prolong ongoing homeostatic or hedonic feeding are context-dependent and more prominent in male than female rodents, but it is not clear where MCH acts to initiate feeding.

View Article and Find Full Text PDF

Melanin-concentrating hormone (MCH) activity in the nucleus accumbens (Acb) has been shown to influence feeding behavior, yet this has not been characterized in terms of homeostatic vs. hedonic feeding processes. Hedonic feeding, driven by palatability rather than energy deficit, can be modeled through intra-Acb administration of the selective μ-opioid receptor agonist d-Ala2, NMe-Phe4, Glyol5-enkephalin (DAMGO), which preferentially increases consumption and incentive motivation to obtain preferred palatable food.

View Article and Find Full Text PDF

Primary cilia are thin hair-like organelles that protrude from the surface of most mammalian cells. They act as specialized cell antennas that can vary widely in response to specific stimuli. However, the effect of changes in cilia length on cellular signaling and behavior remains unclear.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!